{"id":"https://openalex.org/W1344043","doi":"https://doi.org/10.1182/blood.v122.21.3448.3448","title":"A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (\u03b2)-Thalassemia: Interim Results","display_name":"A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (\u03b2)-Thalassemia: Interim Results","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W1344043","doi":"https://doi.org/10.1182/blood.v122.21.3448.3448","mag":"1344043"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.3448.3448","doi":"https://doi.org/10.1182/blood.v122.21.3448.3448","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.3448.3448","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064506274","display_name":"Maria Domenica Cappellini","orcid":"https://orcid.org/0000-0001-8676-6864","observed_orcids":["https://orcid.org/0000-0001-8676-6864"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria-Domenica Cappellini","raw_affiliation_strings":["Ca Granda Foundation IRCCS, University of Milan, Milan, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ca Granda Foundation IRCCS, University of Milan, Milan, Italy,","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049244658","display_name":"John B. Porter","orcid":"https://orcid.org/0000-0003-3000-9359","observed_orcids":["https://orcid.org/0000-0003-3000-9359"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"John Porter","raw_affiliation_strings":["University College London, London, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom,","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009338104","display_name":"Raffaella Origa","orcid":"https://orcid.org/0000-0002-2346-9616","observed_orcids":["https://orcid.org/0000-0002-2346-9616"]},"institutions":[{"id":"https://openalex.org/I172446870","display_name":"University of Cagliari","ror":"https://ror.org/003109y17","country_code":"IT","type":"education","lineage":["https://openalex.org/I172446870"]},{"id":"https://openalex.org/I4210126296","display_name":"Ospedale Microcitemico","ror":"https://ror.org/03neybp41","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210126296"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Raffaella Origa","raw_affiliation_strings":["Universit\u00e0 degli Studi di Cagliari, Ospedale Regionale per le Microcitemie, Cagliari, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 degli Studi di Cagliari, Ospedale Regionale per le Microcitemie, Cagliari, Italy,","institution_ids":["https://openalex.org/I172446870","https://openalex.org/I4210126296"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gian Luca Forni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018768319","display_name":"Ente Ospedaliero Ospedali Galliera","ror":"https://ror.org/05bs6ak67","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I3018768319","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Gian Luca Forni","raw_affiliation_strings":["Ente Ospedaliero Ospedali Galliera, Genoa, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ente Ospedaliero Ospedali Galliera, Genoa, Italy,","institution_ids":["https://openalex.org/I3018768319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044295288","display_name":"Adberrahmane Laadem","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adberrahmane Laadem","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA,","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016689216","display_name":"F. Galact\u00e9ros","orcid":"https://orcid.org/0000-0003-2029-8126","observed_orcids":["https://orcid.org/0000-0003-2029-8126","https://orcid.org/0000-0001-8130-1208"]},"institutions":[{"id":"https://openalex.org/I3019246885","display_name":"Centre Hospitalier Universitaire Henri-Mondor","ror":"https://ror.org/04m61mj84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019246885"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Fr\u00e9d\u00e9ric Galacteros","raw_affiliation_strings":["Groupe Hospitalier Henri Mondor, Cr\u00e9teil, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groupe Hospitalier Henri Mondor, Cr\u00e9teil, France,","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210130325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084870748","display_name":"Dimana Miteva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dimana Miteva","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA,","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007098177","display_name":"Victoria Sung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Victoria Sung","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA,","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111591940","display_name":"Rajesh Chopra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajesh Chopra","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA,","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058318347","display_name":"Jean\u2010Beno\u00eet Arlet","orcid":"https://orcid.org/0000-0003-2608-302X","observed_orcids":["https://orcid.org/0000-0003-2608-302X"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Beno\u00eet Arlet","raw_affiliation_strings":["H\u00f4pital Necker-Enfants Malades, Institut Imagine, Paris, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Necker-Enfants Malades, Institut Imagine, Paris, France,","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I4210165077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001671857","display_name":"Jean\u2010Antoine Ribeil","orcid":"https://orcid.org/0000-0002-4549-4783","observed_orcids":["https://orcid.org/0000-0002-4549-4783","https://orcid.org/0000-0002-5733-9123"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Antoine Ribeil","raw_affiliation_strings":["H\u00f4pital Necker-Enfants Malades, Institut Imagine, Paris, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Necker-Enfants Malades, Institut Imagine, Paris, France,","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I4210165077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024124509","display_name":"Kenneth S. Klesczewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kenneth Klesczewski","raw_affiliation_strings":["Celgene Corporation, Summit, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ, USA,","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051400084","display_name":"Kenneth M. Attie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112018","display_name":"Acceleron Pharma (United States)","ror":"https://ror.org/023annq56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112018"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kenneth Attie","raw_affiliation_strings":["Acceleron Pharma, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acceleron Pharma, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210112018"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015705263","display_name":"Maciej Garbowski","orcid":"https://orcid.org/0000-0001-6441-9562","observed_orcids":["https://orcid.org/0000-0001-6441-9562"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Maciej Garbowski","raw_affiliation_strings":["University College London, London, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London, London, United Kingdom,","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064856085","display_name":"Olivier Hermine","orcid":"https://orcid.org/0000-0003-2574-3874","observed_orcids":["https://orcid.org/0000-0003-2574-3874"]},"institutions":[{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I4210165077","display_name":"Institut des Maladies G\u00e9n\u00e9tiques Imagine","ror":"https://ror.org/05rq3rb55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210100892","https://openalex.org/I4210165077"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Olivier Hermine","raw_affiliation_strings":["H\u00f4pital Necker-Enfants Malades, Institut Imagine, Paris, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital Necker-Enfants Malades, Institut Imagine, Paris, France,","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I4210165077"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5001671857","https://openalex.org/A5007098177","https://openalex.org/A5009338104","https://openalex.org/A5015705263","https://openalex.org/A5016689216","https://openalex.org/A5024124509","https://openalex.org/A5049244658","https://openalex.org/A5051400084","https://openalex.org/A5058318347","https://openalex.org/A5084870748"],"corresponding_institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I172446870","https://openalex.org/I3018768319","https://openalex.org/I3019246885","https://openalex.org/I4210112018","https://openalex.org/I4210126296","https://openalex.org/I4210130325","https://openalex.org/I4210165077","https://openalex.org/I4387155837","https://openalex.org/I45129253"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.147,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.76307265,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"122","issue":"21","first_page":"3448","last_page":"3448"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotatercept","display_name":"sotatercept","score":0.9769999980926514},{"id":"https://openalex.org/keywords/beta-thalassemia-major","display_name":"beta-thalassemia major","score":0.9229999780654907},{"id":"https://openalex.org/keywords/beta-thalassemia-intermedia","display_name":"beta-thalassemia intermedia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6420000195503235},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8790000081062317},{"id":"https://openalex.org/keywords/transfusion-dependence","display_name":"transfusion dependence","score":0.6650000214576721},{"id":"https://openalex.org/keywords/hemoglobin-increase","display_name":"hemoglobin increase","score":0.6389999985694885},{"id":"https://openalex.org/keywords/transfusion-burden","display_name":"transfusion burden","score":0.7080000042915344},{"id":"https://openalex.org/keywords/ineffective-erythropoiesis","display_name":"ineffective erythropoiesis","score":0.8370000123977661},{"id":"https://openalex.org/keywords/iron-metabolism","display_name":"iron metabolism","score":0.7160000205039978},{"id":"https://openalex.org/keywords/bone-metabolism","display_name":"bone metabolism","score":0.7049999833106995},{"id":"https://openalex.org/keywords/dyserythropoiesis","display_name":"dyserythropoiesis","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hemolysis","display_name":"hemolysis","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8057428598403931},{"id":"https://openalex.org/C2780844101","wikidata":"https://www.wikidata.org/wiki/Q2380264","display_name":"Ineffective erythropoiesis","level":4,"score":0.7406235933303833},{"id":"https://openalex.org/C2779703530","wikidata":"https://www.wikidata.org/wiki/Q837174","display_name":"Erythropoiesis","level":3,"score":0.6869410872459412},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.649427056312561},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.6296153664588928},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.6037910580635071},{"id":"https://openalex.org/C2777940137","wikidata":"https://www.wikidata.org/wiki/Q3616632","display_name":"Beta thalassemia","level":3,"score":0.5639793276786804},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48770269751548767},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4584571421146393},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.4211091101169586},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32688766717910767},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.21322128176689148}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.3448.3448","doi":"https://doi.org/10.1182/blood.v122.21.3448.3448","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.3448.3448","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7006119551","https://openalex.org/W2897606226","https://openalex.org/W6995724917","https://openalex.org/W2569943215","https://openalex.org/W2546479491","https://openalex.org/W2618735567","https://openalex.org/W2568094231","https://openalex.org/W1521138540","https://openalex.org/W2980149885","https://openalex.org/W2059065213"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Beta":[2],"(\u03b2)-thalassemia":[3],"is":[4,23,131,193,200,238,297,607,702,707],"characterized":[5],"by":[6,44,202,250],"ineffective":[7,104],"erythropoiesis":[8,49,105],"leading":[9],"to":[10,140,178,196,234,371,384,395,547,601,685],"anemia,":[11],"bone":[12,224,451],"marrow":[13],"erythroid":[14],"hyperplasia,":[15],"iron":[16,221],"overload,":[17],"and":[18,26,112,144,183,223,244,282,290,299,303,308,318,329,351,391,446,488,581,597,609,680,712],"organ":[19],"failure.":[20],"Sotatercept":[21,701],"(ACE-011)":[22],"a":[24,89,97,142,430,439,447,454,460,501,520,531,631,637,643,658],"novel":[25,632],"first-in-class":[27],"activin":[28],"type":[29],"IIA":[30],"receptor":[31],"(ActRIIA)":[32],"fusion":[33],"protein":[34],"that":[35,64,479,661,706],"increases":[36],"the":[37,117,251,272,278,285,293,306,336,346,354,387,398,426,484,494,562,595,666],"release":[38],"of":[39,92,100,120,148,175,216,259,266,325,331,376,441,462,542,634,665,669],"mature":[40],"erythrocytes":[41],"into":[42],"circulation":[43],"acting":[45],"mainly":[46],"on":[47,241,406,617],"late-stage":[48],"(Carrancio":[50],"S,":[51],"et":[52,81,124],"al.":[53,82,125],"Blood.":[54],"2012;120:abstract":[55,127],"372).":[56],"Clinical":[57],"data":[58,242,477,656],"in":[59,69,96,150,209,229,271,277,284,386,397,425,434,453,483,493,505,533,555,591,594,671,714],"healthy":[60],"volunteers":[61],"have":[62,262],"shown":[63],"treatment":[65,577],"with":[66,153,161,438,459,515,636,650,673],"sotatercept":[67,121,149,176,377,516,621,670],"results":[68],"increased":[70],"red":[71],"blood":[72],"cell":[73],"(RBC)":[74],"parameters,":[75],"including":[76],"hemoglobin":[77,203,361,506,523],"level":[78,147,350,507,524,536,558],"(Ruckle":[79],"J,":[80],"J":[83],"Bone":[84],"Miner":[85],"Res.":[86],"2009;24:744-52).":[87],"RAP-011,":[88],"murine":[90],"ortholog":[91],"sotatercept,":[93],"was":[94,366,380,409,559],"efficacious":[95],"mouse":[98],"model":[99],"\u03b2-thalassemia":[101,157,162,316,322,339,456,579,583,652,675],"intermedia,":[102],"reducing":[103],"as":[106,108,226,228,248,265,528,530],"well":[107,227,411,529],"significantly":[109],"improving":[110],"anemia":[111,629],"decreasing":[113],"bilirubin":[114,535,557],"levels,":[115],"supporting":[116],"clinical":[118],"development":[119],"(Dussiot":[122],"M":[123],"Blood":[126],"247).":[128],"Methods":[129],"This":[130],"an":[132,435,610,703],"ongoing":[133],"phase":[134],"2a,":[135],"multicenter,":[136],"open-label,":[137],"dose-finding":[138],"study":[139,468],"determine":[141],"safe":[143],"active":[145],"dose":[146,173,236,349,357,564],"adult":[151],"patients":[152,160,261,314,365,404,492,573,649,672],"RBC-transfusion":[154],"dependent":[155,170],"(TD)":[156],"major":[158,317,457],"or":[159,168,568],"intermedia":[163,323,340,580],"who":[164],"are":[165,180],"either":[166],"TD":[167,455,572],"non-transfusion":[169],"(NTD).":[171],"The":[172,654,677],"levels":[174,237,565],"studied":[177],"date":[179],"0.1,":[181],"0.3,":[182],"0.5":[184,286,294],"mg/kg,":[185],"given":[186],"subcutaneously":[187,623],"once":[188],"every":[189,624],"3":[190,312,394,450,625],"weeks.":[191],"Safety":[192],"assessed":[194,201,709],"according":[195],"NCI-CTC":[197],"grading.":[198],"Efficacy":[199],"increase":[204,504,525],"from":[205,508,526,537],"baseline":[206,360,527,546],"and/or":[207],"reduction":[208,590],"transfusion":[210,592],"burden.":[211],"Secondary":[212],"endpoints":[213],"include":[214],"assessment":[215],"biomarkers":[217],"for":[218,292,362,648,710],"erythropoiesis,":[219],"hemolysis,":[220],"metabolism,":[222,225],"vitro":[230],"dyserythropoiesis.":[231],"Dose":[232],"escalation":[233],"higher":[235],"planned":[239],"contingent":[240],"review":[243],"favorable":[245,638],"safety":[246,639,713],"profile":[247],"determined":[249],"Steering":[252],"Committee.":[253],"Results":[254],"Patient":[255],"demographics.":[256],"A":[257],"total":[258,534,556],"25":[260],"been":[263,587],"enrolled":[264],"July":[267],"26,":[268],"2013;":[269],"8":[270,283,392],"0.1":[273,307,347,388,427,485,596],"mg/kg":[274,280,287,295,310,348,356,389,400,428,486,496,518,567,599],"cohort,":[275,281],"9":[276],"0.3":[279,309,355,399,495,517,569,598],"cohort.":[288],"Treatment":[289],"analysis":[291],"cohort":[296,390,487,497],"underway":[298],"will":[300,612],"be":[301,613],"updated":[302],"presented.":[304,614],"In":[305],"cohorts,":[311],"(18%)":[313],"had":[315,321,498,586],"14":[319],"(82%)":[320],"(12":[324],"whom":[326,332],"were":[327,333,343,414,423,465,574],"NTD":[328,338,364,436,474,651,674],"2":[330,383,432,521],"TD).":[334],"Of":[335],"12":[337],"patients,":[341,475],"6":[342,352,490],"treated":[344,514],"at":[345,353,444,499,545,561],"level.":[358],"Median":[359,374],"these":[363,618],"8.6":[367],"g/dL":[368,503,522],"(range":[369,382,393],"5.8":[370],"10.7":[372],"g/dL).":[373],"number":[375],"doses":[378],"administered":[379,622],"4":[381],"7)":[385],"9)":[396],"cohort;":[401],"13/17":[402],"(76%)":[403],"remained":[405],"treatment.":[407],"Safety.Sotatercept":[408],"generally":[410],"tolerated.":[412],"There":[413,585],"no":[415,588],"dose-limiting":[416],"toxicities":[417],"reported.":[418],"Two":[419],"serious":[420],"adverse":[421],"events":[422],"reported":[424,560],"cohort:":[429],"grade":[431,449],"phlebitis":[433],"patient":[437,458,482,513],"history":[440,461],"high":[442],"D-dimer":[443],"baseline,":[445],"worsening":[448],"pain":[452],"osteoporosis;":[463],"both":[464],"considered":[466],"possibly":[467],"drug-related.":[469],"Hemoglobin":[470],"levels/transfusion":[471],"requirements.":[472],"Among":[473],"preliminary":[476,619],"showed":[478,519],"1":[480,502,512,582],"(17%)":[481],"all":[489],"(100%)":[491],"least":[500],"baseline;":[509],"among":[510],"these,":[511],"decrease":[532,554],"2.7":[538],"\u00d7":[539,549],"upper":[540],"limit":[541],"normal":[543],"(ULN)":[544],"1.8":[548],"ULN.":[550],"No":[551],"other":[552],"relevant":[553],"lower":[563],"(0.1":[566],"mg/kg).":[570],"Three":[571],"still":[575],"receiving":[576],"(2":[578],"major).":[584],"appreciable":[589],"burden":[593],"cohorts":[600],"date;":[602],"however":[603],"further":[604,663],"follow":[605],"up":[606],"warranted":[608],"update":[611],"Conclusion":[615],"Based":[616],"data,":[620],"weeks":[626],"may":[627],"improve":[628],"via":[630],"mechanism":[633],"action":[635],"profile,":[640],"thereby":[641],"addressing":[642],"significant":[644],"unmet":[645],"medical":[646],"need":[647],"intermedia.":[653,676],"current":[655],"suggest":[657],"dose-dependent":[659],"response":[660],"supports":[662],"evaluation":[664],"exposure\u2013effect":[667],"relationship":[668],"first,":[678],"second,":[679],"last":[681],"authors":[682],"contributed":[683],"equally":[684],"this":[686],"abstract.":[687],"Disclosures:":[688],"Cappellini:":[689],"Genzyme:":[690],"Consultancy,":[691,695,717,762],"Speakers":[692,696],"Bureau;":[693],"Novartis:":[694],"Bureau.":[697],"Off":[698],"Label":[699],"Use:":[700],"investigational":[704],"agent":[705],"being":[708],"efficacy":[711],"beta-thalassemia.":[715],"Porter:Novartis:":[716],"Research":[718,725,728,732,763],"Funding;":[719,726,729],"Shire:":[720,727],"Consultancy;":[721],"Celgene:":[722],"Honoraria.":[723],"Forni:Celgene:":[724],"Novartis":[730],"Pharma:":[731,758],"Funding.":[733,764],"Laadem:Celgene":[734],"Corp.:":[735,742,745,750,755],"Employment,":[736,746,751],"Equity":[737,747,752],"Ownership.":[738,748,753],"Galacteros:Celgene:":[739],"Consultancy.":[740],"Miteva:Celgene":[741],"Employment.":[743,756,759],"Sung:Celgene":[744],"Chopra:Celgene":[749],"Klesczewski:Celgene":[754],"Attie:Acceleron":[757],"Hermine:Celgene":[760],"Corporation:":[761]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2016-06-24T00:00:00"}